BXP Q1 2026 Earnings Massive EPS Beat Highlights Operational Resilience OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline Eton Pharmaceuticals Q1 2026 Earnings EPS Miss Triggers Stock Decline ADCT Q1 2026 Earnings EPS Beat Amid Revenue Absence CNI Q1 2026 Earnings EPS Slightly Beats Estimates Amid Stable Operations Sensient Technologies Q1 2026 Earnings Strong EPS Beat Drives Stock Gain